...
机译:在儿科的同种异体移植后复发的危险因素和时间:对谁和何时测试干预措施?
Univ Utah Sch Med Div Hematol &
Hematol Malignancies Huntsman Canc Inst Primary Childrens Hosp;
USC Keck Sch Med Dept Prevent Med Los Angeles CA USA;
Manitoba Blood &
Marrow Transplant Program Winnipeg MB Canada;
Univ British Columbia BC Childrens Hosp Dept Pediat Vancouver BC Canada;
Childrens Hosp Philadelphia Div Oncol Philadelphia PA 19104 USA;
NYU Langone Med Ctr NYU Dept Pediat New York NY USA;
Univ Utah Sch Med Div Hematol &
Hematol Malignancies Huntsman Canc Inst Primary Childrens Hosp;
NYU Langone Med Ctr NYU Dept Pediat New York NY USA;
Univ Pittsburgh Childrens Hosp Pittsburgh Med Ctr Div Blood &
Marrow Transplantat &
Cellular;
Nationwide Childrens Hosp Dept Pathol &
Lab Med Columbus OH USA;
Johns Hopkins Med Inst Dept Pathol Baltimore MD 21205 USA;
Childrens Hosp Philadelphia Div Oncol Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Div Oncol Philadelphia PA 19104 USA;
机译:小儿ALL同种异体移植后的危险因素和复发时机:应针对谁和何时进行干预测试?
机译:第二种降低强度的条件同种异体移植作为急诊RIC同种异体移植后复发的急性白血病患者的抢救策略:危险因素和治疗结果分析
机译:预测移植物与宿主疾病的危险因素,同种异体造血干细胞移植在复发或难治性非霍奇金淋巴瘤中进行复发存活
机译:计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
机译:异基因造血细胞移植治疗慢性粒细胞白血病后的叶酸状况和复发风险。
机译:小儿ALL同种异体移植后的危险因素和复发时机:应针对谁和何时进行干预测试?
机译:在儿科的同种异体移植后复发的危险因素和时间:对谁和何时测试干预措施?